Europska Unija -
hrvatski -
EMA (European Medicines Agency)
oxbryta
pfizer europe ma eeig - voxelotor - anemia; anemia, hemolytic; anemia, sickle cell - other hematological agents - oxbryta is indicated for the treatment of haemolytic anaemia due to sickle cell disease (scd) in adults and paediatric patients 12 years of age and older as monotherapy or in combination with hydroxycarbamide.
Europska Unija -
hrvatski -
EMA (European Medicines Agency)
vafseo
akebia europe limited - vadadustat - renal insufficiency, chronic; anemia - antianemijski pripravci - vafseo is indicated for the treatment of symptomatic anaemia associated with chronic kidney disease (ckd) in adults on chronic maintenance dialysis.